July 22, 2020
News

GNS561, a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition

By 22 July 2020 No Comments

Marseille, July 22, 2020_ Therapeutic Advances in Chronic disease just published Genoscience Pharma’s article E Bestion, ZM Jilkova et al.

See article